Диссертация (1140935), страница 28
Текст из файла (страница 28)
Bondeson, J. Svensson // Scandinavian Journal of Clinical andLaboratory Investigation. – 2011. – Vol. 71, № 2. – P. 139–144.45. Angelini, D. Parathyroid hormone and T-cellular immunity in uremic patients inreplacement dialytic therapy. / D. Angelini, A. Carlini, R.
Giusti [et al.]// Artificial Organs. – 1993. – Vol. 17 (2). – P. 73–75.46. Araujo, M. Oxidative stress in hypertension: role of the kidney. / M. Araujo, C.S.Wilcox // Antioxid. Redox. Signal. – 2014. – Vol. 20 (1). – P. 74-101.47. Arcidiacono, M.V. EGFR activation increases parathyroid hyperplasia andcalcitriol resistance in kidney disease. / M.V. Arcidiacono, T. Sato, D. AlvarezHernandez [et al.] // J. Am. Soc. Nephrol. – 2008. – Vol. 19 (2).
– P. 310–320.48. Ardura, J.A. Parathyroid hormone-related protein protects renal tubuloepithelialcells from apoptosis by activating transcription factor Runx2. / J.A. Ardura, A.B.Sanz, A. Ortiz, P. Esbrit // Kidney Int. – 2013. – Vol. 83 (5). – P. 825-834.49. Artaza, J.N. Vitamin D reduces the expression of collagen and key profibroticfactors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. /J.N. Artaza, K.C. Norris // J. Endocrinol. – 2009. – Vol.
200, № 2. – P. 207–221.50. Atchison, D.K. Parathyroid hormone stimulates juxtaglomerular cell cAMP177accumulation without stimulating renin release / D.K. Atchison, P. Harding, M.C.Ortiz-Capisano, E.L. Peterson, W.H. Beierwaltes // Am. J. Physiol. Renal.Physiol. – 2012.
– Vol. 303 (8). – P. F1157–F1165.51. Atchison, D.K. Parathyroid hormone-related protein stimulates plasma reninactivity via its anorexic effects on sodium chloride intake. / D.K. Atchison, E.Westrick, D.L. Szandzik, K.L. Gordish, W.H. Beierwaltes. // Am. J. Physiol.Endocrinol. Metab. – 2012. – Vol. 303 (4). – P.
E457-463.52. Augustine, M. Parathyroid hormone and parathyroid hormone-related proteinanalogs as therapies for osteoporosis. / M. Augustine, M.J. Horwitz // Curr.Osteoporos. Rep. – 2013. – Vol. 11(4). – P. 400-406.53. Bai,R.J.Rabbit model of primaryhyperparathyroidism induced by high-phosphate diet. / R.J. Bai, X.G.
Cheng, D. Yan, Z.H. Qian, X.M. Li, H. Qu, W.Tian // Domest. Anim. Endocrinol. – 2012. – Vol. 42 (1). – P.: 20-30. doi:10.1016/j.domaniend.2011.09.001.54. Bagó, A.G. Parathyroid hormone 2 receptor and its endogenous ligandtuberoinfundibular peptide of 39 residues are concentrated in endocrine,viscerosensory and auditory brain regions in macaque and human. / A.G.
Bagó,E. Dimitrov, R. Saunders, L. Seress, M. Palkovits, T.B. Usdin, A. Dobolyi //Neuroscience. – 2009. – Vol. 162 (1). – P. 128-147.55. Balin, S.J. Noncognate function of B cells in transplantation. / S.J. Balin, J.L.Platt, M. Cascalho // Transplantation. – 2009.
– Vol. 22. – P. 593–598.56. Barbosa, T.S. Efeito inibidor do soro urêmico sobre o metabolismo oxidativo dosneutrófilos de cães. / T.S. Barbosa, C.K. Mori, P.C. Ciarlini // Arq. Bras. Med.Vet. Zootec. – 2010. – Vol. 62. – P. 1352–1358.57. Bedi, B. Inhibition of antigen presentation and T cell costimulation blocks PTHinduced bone loss.
/ B. Bedi, J.Y. Li, F. Grassi, H. Tawfeek, M.N. Weitzmann, R.Pacifici // Ann. NY. Acad. Sci. – 2010. – Vol. 1192 (1). – P. 215–221.58. Bedi, B. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts thebone anabolic activity of PTH. / B. Bedi, J.Y. Li, H. Tawfeek [et al.] // Proc. Natl.Acad. Sci. USA. – 2012. – Vol. 109 (12).
– P. E725–E733.17859. Betjes, M.G. A killer on the road: circulating CD4(+)CD28null T cells ascardiovascular risk factor in ESRD patients. / M.G. Betjes, R.W. Meijers, L.E. deWit, N.H. Litjens. // J. Nephrol. – 2012. – Vol. 25. – P. 183–191.60. Betjes, M.G. Circulating CD4(+)CD28null T cells may increase the risk of anatherosclerotic vascular event shortly after kidney transplantation. / M.G. Betjes,W.
Weimar, N.H. Litjens. // J. Transplant. – 2013. – Vol. 2013. - 841430.61. Betjes, M.G. Circulating pro-inflammatory CD4posCD28null T cells areindependently associated with cardiovascular disease in ESRD patients. / M.G.Betjes, E.E. de Wit, W. Weimar, N.H. Litjens // Nephrol. Dial. Transplant. –2010.
– Vol. 25. – P. 3640–3646.62. Betjes, M.G. Immune cell dysfunction and inflammation in end-stage renaldisease / M.G. Betjes // Nat. Rev. Nephrol. – 2013. – Vol. 5. – Р. 255-265.63. Betjes, M.G. Premature aging of circulating T cells in patients with end-stagerenal disease. / M.G. Betjes, A.W. Langerak, A. van der Spek, E.A. de Wit, N.H.Litjens. // Kidney Int. – 2011. – Vol. 80. – P. 208–217.64. Betjes, M.G. Terminally differentiated CD8+ Temra cells are associated with therisk for acute kidney allograft rejection. / M.G. Betjes, R.W.
Meijers, E.A. deWit, W. Weimar, N.H. Litjens. // Transplantation. – 2012. – Vol. 94. – P. 63–69.65. Bindels, R.J.M. Transport of calcium, magnesium, and phosphate. / R.J.M.Bindels, J.G.J. Hoenderop, J. Biber, In: B.M. Brenner, editor. // The Kidney. 9thedn. - Philadelphia, PA. - Elsevier Saunders. - 2011. - P. 226–251.66.
Blair, H.C. Parathyroid hormone-regulated production of stem cell factor inhuman osteoblasts and osteoblast-like cells. / H.C. Blair, B.A. Julian, X. Cao,S.E. Jordan, S.S. // Dong. Biochem. Biophys. Res. Commun. – 1999. –Vol. 255.– P. 778–784.67. Blankenberg, S. Plasma concentrations and genetic variation of matrixmetalloproteinase 9 and prognosis of patients with cardiovascular disease. / S.Blankenberg, H.J. Rupprecht, O. Poirier, C.
Bickel, M. Smieja [et al.] //Circulation. – 2003. – Vol. 107. – P. 1579–1585.68. Block, G.A. Therapeutic interventions for chronic kidney disease-mineral and179bone disorders: focus on mortality. / G.A. Block // Curr. Opin. Nephrol.Hypertens. – 2011. – Vol. 20, № 4. – P. 376–381.69. Bodansky, A.Parathormone dosage and serum calcium and phosphorusin experimental chronichyperparathyroidism leading to ostitis fibrosa / A.Bodansky, H.L. Jaffe // J. Exp. Med.
– 1931. – Vol. 53 (5). – P. 591-604.70. Bollerslev, J. Effect of surgery on cardiovascular risk factors in mild primaryhyperparathyroidism. / J. Bollerslev, T. Rosen, C.L. Mollerup [et al.] // Journal ofClinical Endocrinology and Metabolism. – 2009. – Vol. 94, № 7. – P. 2255–2261.71. Boros, S.
Active Ca(2+) reabsorption in the connecting tubule. / S. Boros, R.J.Bindels, J.G. Hoenderop // Pflugers Arch. – 2009. – Vol. 458,№ 1. – P. 99–109.72. Bosworth, C. Parathyroid hormone and arterial dysfunction in the multi-ethnicstudy of atherosclerosis. / C. Bosworth, M.C. Sachs, D. Duprez, A.N.Hoofnagle, [et al.] // Clin.
Endocrinol. (Oxf.). – 2013. – Vol. 79 (3). – P. 429-436.73. Brito Galvao, J.F. Calcitriol, calcidiol, parathyroid hormone, and fibroblastgrowth factor-23 interactions in chronic kidney disease / J.F. Brito Galvao, L.A.Nagode, P.A. Schenck et al. // J. Vet. Emerg. Crit. Care (San Antonio).
– 2013. –Vol. 23(2). – Р. 134–162.74. Brunner, S. Parathyroid hormone effectively induces mobilization of progenitorcells without depletion of bone marrow. / S. Brunner, M.M. Zaruba, B. Huber, R.David, M. Vallaster [et al.] // Exp. Hematol. – 2008. - Vol. 36. – P. 1157–1166.75. Calvi, L.M. Osteoblastic cells regulate the haematopoietic stem cell niche. /L.M. Calvi, G.B. Adams, K.W.
Weibrecht [et al.]. // Nature. – 2003. - Vol. 425(6960). – P. 841-846.76. Calvo, N. Pro-apoptotic effects of parathyroid hormone in intestinal cells. /N. Calvo, O. German, A. Russo de Boland, C. Gentili // Biochem. Cell. Biol. –2009. – Vol. 87 (2). – P. 389-400.77. Canaff, L. Human calcium-sensing receptor gene. Vitamin D response elementsin promoters P1 and P2 confer transcriptional responsiveness to 1,25dihydroxyvitamin D. / L. Canaff, G.N. Hendy // J. Biol. Chem.
– 2002. – Vol.277 (33). – P. 30337–30350.18078. Canalis, E. Mechanisms of anabolic therapies for osteoporosis. / E. Canalis, A.Giustina, J.P. Bilezkian // N. Engl. J. Med. – 2007. – Vol. 357. – P. 905–916.79. Cao, Y. PTHrP is a novel mediator for TGF-β-induced apoptosis / Y. Cao, W.Zhang, X. Gao, G. Zhang, M. Falzon, C.M. Townsend, Jr., M.R. Hellmich, T.C.Ko // Regul. Pept. – 2013. – Vol.
184. – P. 40–46.80. Caron, N.R. What symptom improvement can be expected after operation forprimary hyperparathyroidism? / N.R. Caron, J.L. Pasieka. // World Journal ofSurgery. – 2009. – Vol. 33, № 11. – P. 2244–2255.81. Castellanos, M. Effect of parathyroid hormone and teriparatide on immunefunction of human adherent and non-adherent leukocytes. / M. Castellanos, E.Jung, S.Y. Park, G. Schuller-Levis, M. Odaimi, S. Elsayegh, M.
Kleiner, R.Elsoueidi, N. Shtaynberg, E. Park // Clin. Nephrol. – 2010. - Aug, Vol. 74, № 2.– P. 83-90.82. Chandra, A. PTH1-34 blocks radiation-induced osteoblast apoptosis byenhancing DNA repair through canonical Wnt pathway. / A. Chandra, T. Lin, J.Zhu, W. Tong [et al.]. // J. Biol. Chem. – 2015.
– Vol. 290 (1). – P. 157-167.83. Chang, J-H. Calcitriol treatment attenuates inflammation and oxidative stress inhemodialysis patients with secondary hyperparathyroidism. / J-H. Chang, C-C.Chen [et al.] // Tohoku Journal of Experimental Medicine. – 2011. – Vol. 223 (3).– P. 153–159.84.
Chang, E. Parathyroid hormone suppresses insulin signaling in adipocytes. /E. Chang, S.S. Donkin, D. Teegarden // Mol. Cell. Endocrinol. – 2009.- Vol. 307(1-2). – P. 77-82.85.Chattopadhyay, P. Calcium antagonist prevents calcium flux induced necrosisand apoptosis in ischemic reperfusion of rat liver.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
